U.S. Wireless Telecom Stock News

Sierra Bancorp (BSRR) opened Q1 2026 with Q4 2025 revenue of about US$40.2 million and basic EPS of roughly US$0.97, set against trailing twelve month revenue of about US$149.2 million and EPS of around US$3.14. Earnings over the past year grew 4.4%, while the longer five year trend shows a modest 0.1% annual decline. Over recent quarters, revenue has moved from about US$35.5 million in Q4 2024 to US$40.2 million in Q4 2025, while quarterly basic EPS has ranged between roughly US$0.66 and...

Investors may be wondering whether Howmet Aerospace's share price still offers value after a strong run, or if most of the easy gains are already behind it. The stock closed at US$241.70, with a 5.4% decline over the last 7 days, a 6.1% gain over 30 days, a 14.2% gain year to date, and a 77.7% gain over 1 year. It has also delivered a very large 3 year return and an even higher 5 year return, which puts recent moves into context. Recent attention on Howmet Aerospace has focused on its role...

Wondering if Fresh Del Monte Produce at around US$41.81 is offering fair value right now, or if the current price is leaving something on the table for you? The stock has returned 1.0% over the last week, is roughly flat over 30 days with a 0.2% decline, and sits on returns of 18.4% year to date and 25.2% over 1 year, with 3 and 5 year returns of 61.4% and 65.2% respectively. Recent performance has kept Fresh Del Monte Produce on the radar for investors looking at food and agriculture...

Aehr Test Systems completed a $60 million follow on equity offering. The company trades on NasdaqCM under the ticker AEHR. The equity raise is a material event that could affect funding capacity and future corporate decisions. Aehr Test Systems (NasdaqCM: AEHR) now has a fresh $60 million in equity capital following its follow on offering. The stock most recently closed at $88.45, after very large gains over the past year and multi year period, including a 172.0% return over the past 30...

Domino's Pizza (DPZ) kicked off Q1 2026 with investors watching how its recent Q4 2025 revenue of US$1.5b and basic EPS of US$5.35 stack up against last year's Q4 2024 figures of US$1.4b in revenue and EPS of US$4.89. Over the past year, the company has seen quarterly revenue move from US$1.1b in Q1 2025 to US$1.5b in Q4 2025, while basic EPS ranged from US$3.84 to US$5.35. This sets the stage for a results season where margin quality and consistency matter as much as headline growth. See our...

Norwood Financial’s latest earnings in focus Norwood Financial (NWFL) opened 2026 with Q1 results that sit on top of a turnaround year, coming off Q4 2025 revenue of US$23.0 million and net income of US$7.4 million, equal to EPS of US$0.81, after a loss in Q4 2024 when revenue was US$2.6 million and net income was US$12.7 million in the red with EPS of US$1.54 in the red. Over the past few reported quarters, revenue has moved from US$16.9 million in Q3 2024 to US$19.4 million in Q1 2025 and...

On April 22, 2026, Goosehead Insurance, Inc. reported Q1 2026 results showing higher revenue and net income year over year, while simultaneously promoting Mark Jones, Jr. to President and Chief Operating Officer and appointing John Martin as Chief Financial Officer. The company also completed a substantial share repurchase program, retiring about 8.02% of its stock for US$131.51 million, which may affect future per-share metrics and capital allocation flexibility. We’ll now examine how...

Verizon Communications (VZ) has just wrapped up Q1 2026 with its recent numbers anchored by Q4 2025 results, where revenue came in at US$36.4b and basic EPS was US$0.55 on net income of US$2,342m. Over the past few quarters, revenue has moved from US$33.5b in Q1 2025 to US$36.4b in Q4 2025, while basic EPS over that stretch ranged between US$0.55 and US$1.18. This gives investors a clear view of how the top line and per share earnings have tracked into this latest update. With trailing net...

Lakeland Financial (LKFN) opened 2026 with Q1 results that sit against a trailing twelve month backdrop of US$257.2 million in revenue and basic EPS of US$4.02, supported by net income of US$103.4 million over that period. Over recent quarters, revenue has moved from US$58.1 million in Q3 2024 to US$60.9 million in Q4 2024 and US$69.8 million in Q4 2025, while quarterly basic EPS has ranged from US$0.91 in Q3 2024 to US$0.94 in Q4 2024 and US$1.17 in Q4 2025. This gives investors a clearer...

Upcoming earnings report puts focus on Kirby’s mixed expectations Kirby (KEX) heads into its upcoming quarterly earnings report with Wall Street expecting higher revenue and earnings, while recent analyst estimate revisions point to more cautious sentiment around the company’s near term profit potential. See our latest analysis for Kirby. Recent price action has been strong, with a 36.18% year to date share price return and a 59.09% total shareholder return over the past year. This suggests...

Bank of Marin Bancorp (BMRC) has just put Q1 2026 in context with a recent quarter that included total revenue of about US$28.5 million and a basic EPS loss of US$2.24, alongside trailing twelve month figures that still reflect unprofitable results. Over recent periods, the company has seen quarterly revenue move from US$24.9 million in Q4 2024 to US$27.7 million in Q1 2025 and US$30.9 million in Q3 2025. Basic EPS has swung between a profit of US$0.62 and a loss of US$2.49, setting up a...

In April 2026, Waterschap Aa en Maas in the Netherlands and Northern Ireland Water selected Tetra Tech to deliver multi-year engineering, consulting, and high-end sampling services to modernize wastewater treatment, safeguard water quality, and enhance flood resilience across their regions. These wins highlight growing international uptake of Tetra Tech’s advanced data analytics and water management software, reinforcing its role in complex, regulated water infrastructure projects across...

Easterly Government Properties (DEA) opened Q1 2026 with trailing twelve month revenue of US$342.9 million and EPS of US$0.27, set against a net profit margin of 3.6% versus 6.2% a year earlier. Over recent quarters the company has seen revenue move from US$308.1 million and EPS of US$0.46 in Q4 2024 to US$342.9 million and EPS of US$0.27 in Q4 2025. Trailing earnings have been described as showing negative growth of 7.5% annually over five years, and analysts embed forecasts of about 4%...

Spotify Technology (NYSE:SPOT) is partnering with Peloton to add a new fitness category to its platform. The partnership gives Spotify Premium users access to over 1,400 ad free on demand Peloton classes. The new content offering is positioned as a way to broaden engagement beyond music and podcasts. For Spotify, which built its business around music streaming and later moved into podcasts, teaming up with Peloton adds another type of audio and video content that people can use daily...

Before weighing up whether CrowdStrike Holdings is attractively priced, you probably want to know if the current share price reflects the business you are actually buying or if expectations have run ahead of fundamentals. CrowdStrike's stock has been active recently, with the last close at US$454.61 after returns of 5.0% over 7 days, 23.0% over 30 days, 0.2% year to date, 7.5% over 1 year, 282.7% over 3 years and 121.6% over 5 years. This performance can influence how the market views both...

What Jade Biosciences’ Recent Move Means For Investors Jade Biosciences (JBIO) has caught investor attention after a sharp share price move over the past month, prompting a closer look at how its current fundamentals and recent trading performance line up. See our latest analysis for Jade Biosciences. At a share price of US$24.98, Jade Biosciences has seen momentum build, with a 7 day share price return of 6.3%, a 30 day share price return of 86.6% and a year to date share price return of...

In April 2026, InMode Ltd. reaffirmed its revenue guidance, projecting US$81.5 million to US$81.7 million for first-quarter 2026 and US$365 million to US$375 million for full-year 2026. This confirmation of management’s outlook underscores the company’s confidence in its current operating trajectory and demand visibility across its aesthetic medical device portfolio. Now we’ll examine how reaffirmed 2026 revenue guidance might influence InMode’s investment narrative built around growth,...

Event driven snapshot of MGIC Investment With no specific headline event setting the tone today, MGIC Investment (MTG) continues to trade around recent levels. This invites investors to reassess how its current share price lines up with its fundamentals and past returns. See our latest analysis for MGIC Investment. Recent trading has been shaped more by a steady grind higher than by sharp moves. A 30 day share price return of 11.31% and a 90 day gain of 8.08% sit alongside a year to date...

Carlisle Companies reported past first-quarter 2026 results with sales of US$1,052.1 million and net income of US$127.7 million, both slightly lower than a year earlier, while earnings per share were broadly stable. Despite weaker revenue, Carlisle expanded margins, reaffirmed its 2026 guidance for low single-digit revenue growth, and continued sizable share repurchases, including 700,000 shares bought back in the quarter. Next, we will examine how Carlisle’s margin expansion amid softer...

Even when a business is losing money, it's possible for shareholders to make money if they buy a good business at the...

Belite Bio (BLTE) has begun a rolling New Drug Application submission to the U.S. Food and Drug Administration for tinlarebant, its oral therapy candidate for Stargardt disease type 1. This marks a key late stage regulatory step. See our latest analysis for Belite Bio. Despite the recent NDA progress and upcoming conference appearances, Belite Bio’s share price return over the past week and quarter has been slightly negative. Its 1 year total shareholder return is very large and its 3 year...

Pharvaris (NasdaqGS:PHVS) is back in focus after new conference data supported the safety of combining its deucrictibant extended release tablet for prophylaxis with immediate release capsules for treating hereditary angioedema breakthrough attacks. See our latest analysis for Pharvaris. The latest conference data seems to have kept interest in Pharvaris alive, with a 1-year total shareholder return of 67.82% and a 3-year total shareholder return above 2x. At the same time, the 90-day share...

Over the last 7 days, the United States market has remained flat, yet it has experienced a significant 30% increase over the past year with earnings projected to grow by 16% annually. In this environment, identifying stocks that may be trading below their estimated fair value can present opportunities for investors seeking potential long-term gains.

The United States market remained flat over the last week, yet it has experienced a 30% rise over the past 12 months with earnings forecasted to grow by 16% annually. In this context of robust growth potential, identifying high-growth tech stocks involves focusing on companies that demonstrate strong innovation and adaptability to capitalize on emerging opportunities.